N30 Announces Initiation of Phase 1 Trials of Novel Reductase Inhibitor
Comments are closed.
N30 Pharma Names Evan Loh, MD and John R. Moore to Board of Directors
N30 CCFA Fall 2011 conference poster
N30 ACS Fall 2011 meeting poster
N30 GRC Summer 2011 meeting poster
N30 ATS 2011 meeting poster
Copyright © 2012 N30 Pharmaceuticals - All Rights Reserved